COLON-MD: Colon Cancer Longitudinal Study
NCT04751448 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 11
Last updated 2026-01-26
Summary
The goal of this proposal is to identify how the composition of the gut microbiome and diet interact to impact chemotherapy-induced diarrhea incidence and severity.
Conditions
Sponsors & Collaborators
-
Baylor University
collaborator OTHER -
Baylor Research Institute
lead OTHER
Eligibility
- Min Age
- 18 Years
- Max Age
- 79 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-02-01
- Primary Completion
- 2026-06-01
- Completion
- 2026-06-01
Countries
- United States
Study Locations
More Related Trials
-
Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Recurrent or Persistent Metastatic Colorectal Cancer
NCT00023933 ·Status: COMPLETED ·Phase: PHASE1
-
Bryostatin 1 in Treating Patients With Metastatic Colorectal Cancer
NCT00003220 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of Xeloda (Capecitabine) in Patients With Advanced and/or Metastatic Colorectal Cancer
NCT00048139 ·Status: COMPLETED ·Phase: PHASE2
-
Study of Target-Guided Chemotherapy in Metastatic Colorectal Patients
NCT01453257 ·Status: COMPLETED ·Phase: PHASE2
-
Lactobacillus Rhamnosus in Prevention of Chemotherapy-related Diarrhoea
NCT00197873 ·Status: COMPLETED ·Phase: NA
-
Gene Expression Analysis of Patients With Metastatic Colorectal Cancer Receiving Oxaliplatin Based Chemotherapy Regimen
NCT00250029 ·Status: COMPLETED ·Phase: NA
-
Neoadjuvant Treatment of Colon Cancer
NCT01108107 ·Status: COMPLETED ·Phase: PHASE2
-
A Biomarker Study in Patients Getting Regorafenib for Metastatic Colorectal Cancer
NCT02402036 ·Status: TERMINATED ·Phase: PHASE2
-
Irinotecan in Treating Patients With Metastatic or Recurrent Colorectal Cancer
NCT00002933 ·Status: COMPLETED ·Phase: PHASE2
-
Tocladesine in Treating Patients With Recurrent or Progressive Metastatic Colorectal Cancer
NCT00021268 ·Status: UNKNOWN ·Phase: PHASE1
-
Azacitidine and CAPOX in Metastatic Colorectal Cancer
NCT01193517 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
GW572016, An Oral Drug For Colorectal Cancer Patients Having Prior Therapy With 5-FU Plus CPT-11 And/Or Oxaliplatin
NCT00044343 ·Status: COMPLETED ·Phase: PHASE2
-
Intraperitoneal and System Chemotherapy Versus XELOX as First-line Chemotherapy for mCRC
NCT03792269 ·Status: UNKNOWN ·Phase: PHASE2
-
Study of Colon GVAX and Cyclophosphamide in Patients With Metastatic Colorectal Cancer
NCT00656123 ·Status: COMPLETED ·Phase: PHASE1
-
Bemalenograstim Alfa for the Prevention in Patients With Colorectal Cancer/Pancreatic Cancer
NCT06134765 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Phase II Trial of Lapatinib & Capecitabine for Patients With Refractory Advanced Colorectal Adenocarcinoma
NCT00574171 ·Status: COMPLETED ·Phase: PHASE2
-
Low Dose Metronomic Poly-chemotherapy for Metastatic CRC
NCT02280694 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of Capecitabine (Xeloda) in Patients With Metastatic Colorectal Cancer
NCT02567331 ·Status: COMPLETED ·Phase: PHASE4
-
Longitudinal Study of Symptoms in Colorectal Cancer
NCT00777192 ·Status: TERMINATED
-
Fecal Microbiota Transplantation With Immune Checkpoint Inhibitors in Lung Cancer
NCT05502913 ·Status: RECRUITING ·Phase: PHASE2
-
Fecal Microbiota Transplant and Re-introduction of Anti-PD-1 Therapy (Pembrolizumab or Nivolumab) for the Treatment of Metastatic Colorectal Cancer in Anti-PD-1 Non-responders
NCT04729322 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Combination Immunotherapy in Colorectal Cancer
NCT05571293 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
For Prevention of Diarrhea in Patients Diagnosed With Metastatic Colorectal Cancer Treated With Chemotherapy
NCT00037180 ·Status: TERMINATED ·Phase: PHASE2
-
Chidamide + Celecoxib in Advanced Metastatic Colorectal Cancer (CCmCC)
NCT05281276 ·Status: TERMINATED ·Phase: PHASE1
-
Rebeccamycin Analog in Treating Patients With Metastatic or Locally Recurrent Colorectal Cancer
NCT00005085 ·Status: COMPLETED ·Phase: PHASE2